Russ Altman blogs about his "first official 'post-genomic' personal moment." An advisor to 23andMe, Altman has his genotype information from the company and found himself looking up particular alleles after reading a paper in the New England Journal of Medicine about genetic variation in statin response. "In about 30 seconds I went from reading an article of potential interest to checking my genotype and drawing a preliminary conclusion about my own future actions," Altman writes. "I anticipate we all will have more of these moments, but I must say it was quite quick, informative, even fun."
Meanwhile, here's a Tech Review interview with 23andMe co-founders Linda Avey and Anne Wojcicki. They discuss how customers can share genomic information with each other, how the data can be used to make medical decisions, and more.